Hicham Alaoui

Company: Glycomine

Job title: Chief Scientific Officer

Seminars:

Characterization of Anti-PEG Antibodies to Support Clinical Development of GLM101, a Liposome-Based Therapeutic Candidate for PMM2-CDG 10:00 am

Clinical feedback on liposome product given to patients chronically Optimal strategy on collecting immunogenicity data Exploring the impact of PEG antibodies on clinical performanceRead more

day: Day One